GlassScriptPhysician profile
Michael Suk
NPI 1699736793
$270,238.30
in general payments reported to CMS, 2019-2025
28 companies · $50K in 2025
The $50K reported for 2025 was more than what 95% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $50K · 2020: $1,447 · 2021: $25K · 2022: $42K · 2023: $50K · 2024: $52K · 2025: $50K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $98K · Travel and Lodging: $38K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $9,000 · Food and Beverage: $6,099.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $98,287.50 |
| Travel and Lodging | $38,449.53 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $9,000.00 |
| Food and Beverage | $6,099.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $96,977.58 | 2019-2025 | Axsos, Mako, T2 Alpha |
| Globus Medical, INC. | $57,115.49 | 2019-2025 | Periprosthetic Fracture, Clavicular Fracture Fixation, Excelsius Gps |
| Acumed LLC | $46,038.23 | 2019-2024 | Acumed |
| Medacta USA, INC. | $32,248.75 | 2019-2025 | Gmk Sphere, Amistem, Nextar Knee |
| Linvatec Corporation | $11,784.09 | 2019-2025 | Biobrace 23mm, Livatec Knee Preservation System, Hall Power |
| Medical Device Business Services, INC. | $6,896.41 | 2019-2025 | Tfn-Advance |
| US Implant Solutions, LLC | $6,738.45 | 2025 | |
| Arthrex, INC. | $3,539.09 | 2022-2025 | |
| Smith+Nephew, INC. | $3,460.07 | 2019-2025 | Grafix, Pico 7, Renasys Touch |
| Novus Surgical Consultants | $1,914.72 | 2024-2025 | |
| Novus Surgical Solutions LLC | $1,167.26 | 2022 | |
| Next Science LLC | $987.01 | 2022-2023 | Xperience, Blastx, Surgx |
| The Institute of Musculoskeletal Science and Education | $411.75 | 2019 | |
| Depuy Synthes Sales INC. | $366.08 | 2019-2025 | Tfn-Advance, Va-Lcp |
| Steris Corporation | $138.48 | 2022 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Illuminoss Medical, INC. | $75.95 | 2023-2025 | Photodynamic Bone Stabilization Procedure Pack |
| Sanara Medtech INC. | $68.78 | 2022-2023 | Celleraterx |
| Pacira Pharmaceuticals Incorporated | $66.58 | 2019 | |
| Orthosensor INC. | $56.22 | 2019 | |
| Zimmer Biomet Holdings, INC. | $50.11 | 2020 | |
| Covidien LP | $33.98 | 2019 | |
| Baxter Healthcare | $32.95 | 2022 | |
| Augmedics INC. | $15.51 | 2021 | |
| Lima USA, INC. | $15.00 | 2019 | |
| Exactech, INC. | $13.75 | 2019 | |
| Heron Therapeutics, INC. | $13.10 | 2022 | |
| Radius Health, INC. | $12.91 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Suk listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.